A study presented results from a week 16 analysis of tildrakizumab, an interleukin-23 inhibitor, for the treatment of moderate to severe plaque psoriasis of the scalp. Results showed that a significantly higher proportion of patients treated with tildrakizumab achieved clearance of their scalp psoriasis compared to placebo. Adverse events were reported more in the tildrakizumab…
The article discusses how Western drug makers are seeking alternative suppliers in response to draft U.S. legislation that would restrict working with certain Chinese biotechs. These Chinese companies produce active pharmaceutical ingredients for many U.S. and European drugmakers, prompting companies like Eli Lilly and Vertex Pharmaceuticals to diversify production. In other news, European regulators found…
A study found that treatment with ticagrelor alone, rather than in combination with aspirin, led to a lower rate of clinically relevant bleeding in patients with acute coronary syndrome who underwent percutaneous coronary intervention. The study involved adults who remained event-free for one month on dual antiplatelet therapy after their procedure. Participants were randomly assigned…
A team of researchers led by Huanyu “Larry” Cheng at Penn State developed wearable sensors and a machine learning algorithm to monitor infant movements for early detection of neuromotor diseases. The pilot study showed up to 99.9% accuracy in identifying at-risk infants. This technology is needed to detect issues early, before irreversible damage occurs. The…
Lauren Nicks recalls experiencing adultification bias at a summer camp, where she was scolded for her clothing and perceived as more mature than her age. This bias disproportionately affects Black girls, who are often treated harshly in education and juvenile justice systems. Signs of trauma from this bias can include changes in behavior or academic…
A phase 2 trial investigating a new drug, ninerafaxstat, showed promising results in improving cardiac function in patients with nonobstructive hypertrophic cardiomyopathy (nHCM). While overall cardiovascular outcomes did not show significant improvement, a post hoc analysis revealed that patients with severe symptoms experienced measurable improvements in heart failure symptoms and exercise capacity. This suggests potential…
Lupin has received approval from the CDSCO panel to study a powder for inhalation capsule containing Glycopyrronium Bromide and Vilanterol Trifenatate. This medication is intended for the treatment of respiratory conditions. The company will conduct further research on the product. Cookies are used on the website for analytics and advertising purposes. Continuing to use the…
The traditional fee-for-service healthcare model has been foundational in providing access to healthcare services, but as the industry shifts towards outcomes-based care, specialty practices face unique challenges and opportunities. These practices, including dermatology, ophthalmology, and aesthetics, can lead in healthcare innovation by integrating medical wellness into their services. The focus on wellness aligns with consumer…
The Belfast Health and Social Care Trust is seeking a Consultant in Palliative Medicine, with the opportunity for a joint appointment at the Marie Curie Hospice. The role involves working with community-based colleagues to develop a community service for patients in the Belfast Trust area. The closing date for applications is 16th May 2024 at…
Smith & Nephew has launched its Renasys Edge negative pressure wound therapy system, designed to discreetly treat patients with chronic wounds like ulcers. The system can be carried or worn, allowing patients to go about their daily lives while receiving the prescribed therapy. Smith & Nephew is partnering with SunMed Medical Solutions and First Nation…
